||Obesity is a chronic disease with deleterious effects on health and well-being, but BMI is an imperfect proxy for health risk. This symposium, hosted by the NIH Obesity Research Task Force and presented by renowned extramural investigators, will explore the heterogeneity of obesity, including risk for its development and complications, pathophysiology, and response to treatment, as well as implications for implementing obesity prevention and treatments.
“The Role of Adipocytes and Adipose Tissue Metabolism in the Heterogeneity of Obesity”
Philipp E. Scherer, Ph.D.
Touchstone Diabetes Center
The University of Texas Southwestern Medical Center
“Metabolically Healthy and Unhealthy Obesity”
Samuel Klein, M.D.
Center for Human Nutrition
Washington University School of Medicine
“Metabolically Healthy Obesity and Cardiovascular Disease Risk: Fact or Fiction?”
Yvonne Commodore-Mensah, Ph.D., MHN, RN
Johns Hopkins School of Nursing
Johns Hopkins Bloomberg School of Public Health
“Genetic Subclassification of Obesity and its Role in Precision Health”
Ruth Loos, Ph.D.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences University of Copenhagen
“Heterogeneity of Obesity in Children from Diverse and Immigrant/Refugee Households: Using Machine Learning to Inform Intervention Targets”
Jerica M. Berge, Ph.D., MPH, LMFT, CFLE
Department of Family Medicine and Community Health University of Minnesota Medical School and Allan Tate, Ph.D.
Department of Epidemiology and Biostatistics University of Georgia